跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2603.22399 · v2

Latent Style-based Quantum Wasserstein GAN for Drug Design

首次提交 2026-03-24 02:00
版本更新 2026-10-28 16:58
雷达观测 2026-10-30 10:22
arXiv ↗PDF ↗

摘要

The development of new drugs is a time-consuming and expensive process, with average costs estimated to be up to around $2.5 billion. The first step in this process is the design of the new drug, for which de novo drug design, assisted by artificial intelligence, has blossomed in recent years and has revolutionized the field. In particular, generative artificial intelligence has delivered promising results in drug discovery and development, reducing costs and time to solution. However, classical generative models, such as generative adversarial networks (GANs), can be difficult to train and are prone to mode collapse. Quantum computing may be an avenue to overcome some of these issues, providing compact models with far fewer trainable parameters, thereby enhancing the generalizability of GANs. We propose a new latent style-based quantum Wasserstein GAN (QGAN) for drug design, combining a variational autoencoder that maps molecular structures into a latent space with a hybrid quantum GAN. Our pipeline is benchmarked against classical models of the industry-relevant MOSES suite. Style-based noise reuploading at every rotational gate and a Wasserstein gradient penalty are used to improve trainability and to mitigate mode collapse. Training and large-scale sampling with circuits of up to 15 qubits are performed on noiseless quantum simulators to validate our architecture. We present an inference-only demonstration on an IBM Heron quantum computer using 5 qubits, sampling 2,500 new molecules, to investigate quantum noise effects. Our default QGAN, using 110 trainable generator parameters, reaches statistically comparable overall performance and statistically significant gains on selected drug-relevant metrics relative to both the MOSES classical latent GAN baseline, which contains about 700,000 trainable parameters for the generator, and a classical latent GAN with matched generator capacity.

作者备注:Main part: 26 pages, 11 figures, 6 tables. Supplementary material: 24 pages, 20 figures, 21 tables. v2: revision containing matched-capacity analysis of the classical GAN and extensive details on the hardware inference run, plus bootstrap error analysis of the hardware results. Matches published version

期刊信息:J. Chem. Inf. Model. (2026) 66 (20): 13136-13154

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

目前只观测到一个版本,无法比较变化。之后收录新版本时,会在这里对照标题、作者、分类和摘要。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v2 · 2026-10-28 16:58 · 最新观测版本

Latent Style-based Quantum Wasserstein GAN for Drug Design

The development of new drugs is a time-consuming and expensive process, with average costs estimated to be up to around $2.5 billion. The first step in this process is the design of the new drug, for which de novo drug design, assisted by artificial intelligence, has blossomed in recent years and has revolutionized the field. In particular, generative artificial intelligence has delivered promising results in drug discovery and development, reducing costs and time to solution. However, classical generative models, such as generative adversarial networks (GANs), can be difficult to train and are prone to mode collapse. Quantum computing may be an avenue to overcome some of these issues, providing compact models with far fewer trainable parameters, thereby enhancing the generalizability of GANs. We propose a new latent style-based quantum Wasserstein GAN (QGAN) for drug design, combining a variational autoencoder that maps molecular structures into a latent space with a hybrid quantum GAN. Our pipeline is benchmarked against classical models of the industry-relevant MOSES suite. Style-based noise reuploading at every rotational gate and a Wasserstein gradient penalty are used to improve trainability and to mitigate mode collapse. Training and large-scale sampling with circuits of up to 15 qubits are performed on noiseless quantum simulators to validate our architecture. We present an inference-only demonstration on an IBM Heron quantum computer using 5 qubits, sampling 2,500 new molecules, to investigate quantum noise effects. Our default QGAN, using 110 trainable generator parameters, reaches statistically comparable overall performance and statistically significant gains on selected drug-relevant metrics relative to both the MOSES classical latent GAN baseline, which contains about 700,000 trainable parameters for the generator, and a classical latent GAN with matched generator capacity.

查看此版本解读 →查看此版本原文 ↗